Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Topic selection
Guidance in topic selection
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Technology type
Technology type
Device (1)
Medicine (17)
Procedure (1)
Topic selection decision
Topic selection decision
Awaiting decision (1)
Not selected (18)
Type
Type
Guidance (19)
Apply filters
Showing 1 to 19 of 19
Sort by
Decision date
Title
Apply sorting
Keyword or reference number: children
Remove Keyword or reference number: children filter
Guidance in topic selection
Title
Technology type
Decision
Decision date
Ustekinumab for treating moderately to severely active ulcerative colitis in
children
aged 2 to 17 years [TSID 12128]
Medicine
Not selected
4 February 2025
Berotralstat for preventing recurrent attacks of hereditary angioedema in
children
aged 2 to 12 years [TSID 12132]
Medicine
Not selected
4 February 2025
Lebrikizumab for treating atopic dermatitis in
children
[TSID 12133_TSID 12135]
Medicine
Not selected
4 February 2025
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in
children
1 to 6 years [TSID12092]
Medicine
Not selected
14 November 2024
Evinacumab for treating homozygous familial hypercholesterolemia in
children
aged 5 to 11 [TSID11806]
Medicine
Not selected
1 November 2024
Mexiletine hydrochloride for treating myotonia in
children
and adolescents with myotonic disorders [TS ID 11978]
Medicine
Not selected
10 September 2024
Ferric maltol for treating iron deficiency anaemia in
children
and adolescents aged 1 month to 17 years TS ID 11994
Medicine
Not selected
19 July 2024
Guselkumab for treating chronic plaque psoriasis in
children
aged 6 to 17 years [TSID12002]
Medicine
Not selected
26 March 2024
Ivacaftor for treating cystic fibrosis with mutations in the CFTR gene in babies and
children
aged 1 to 3 months or weighing 3 kg to 24 kg [TSID11894]
Medicine
Not selected
12 September 2023
Spineform Hemibridge endoscopic vertebral stapling to reduce curvature in the growing scoliotic spine in
children
Procedure
Not selected
4 September 2023
Elexacaftor–tezacaftor–ivacaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in
children
aged 2 to 5 [TSID10767]
Medicine
Not selected
6 April 2023
Baricitinib for treating moderate to severe atopic dermatitis in
children
and young people aged 2 to 17 [TSID10639]
Medicine
Not selected
14 February 2023
Subcutaneous belimumab for treating systemic lupus erythematosus in
children
aged 5 to 17 [TSID11828]
Medicine
Not selected
7 February 2023
Dulaglutide for treating type 2 diabetes in
children
and young people [TSID10660]
Medicine
Not selected
25 May 2022
Dupilumab for
children
with severe atopic dermatitis [TSID10434]
Medicine
Not selected
25 April 2022
Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in
children
6 to 11 years [TSID10085]
Medicine
Not selected
17 January 2022
Moor LDLS-BI for assessing burn depth and healing potential in
children
and adults
Device
Not selected
6 May 2021
Fingolimod for treating relapsing multiple sclerosis in
children
and young people [ID1378]
Medicine
Not selected
20 September 2018
Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in
children
TSID 12106
Medicine
Awaiting decision
TBC
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top